Key result
Increased intake of β-carotene, lutein/zeaxanthin, and lycopene was associated with a lower risk of MAFLD, with a U-shaped association for lycopene (P<.001) primarily observed in females.
Why the study?
Carotenoids have recognized antioxidant health benefits, but there is limited research on the association between metabolic dysfunction-associated fatty liver disease and carotenoid intake.
Does increased carotenoid intake reduce the risk of MAFLD in adults?
Cross-Sectional (n=2,722)
Does increased carotenoid intake reduce the risk of MAFLD in adults?
Increased dietary intake of specific carotenoids, particularly lycopene in females, is associated with a decreased risk of metabolic dysfunction-associated fatty liver disease.
Answers are grounded in this paper and cite their sources.
Higher carotenoid intakes may inform MAFLD dietary risk assessment; leaves open causality and needs prospective confirmation before practice change.
Carotenoids have been recognized for their potential health benefits due to their antioxidant properties. There is limited research on the association between metabolic dysfunction-associated fatty liver disease (MAFLD) and carotenoids. This study aimed to investigate the effect of carotenoid intake on the risk of MAFLD. We retrospectively analyzed 2722 adults aged ≥ 18 from the National Health and Nutrition Examination Survey 2017-2018. Hepatic steatosis was identified by elastography, and carotenoid consumption was evaluated through two 24-hour dietary recall interviews. Weighted logistic regression models, subgroup analyses, and restricted cubic splines were used for analyses. The weighted prevalence of MAFLD was 51.90%. Weighted logistic regression analysis demonstrated that intake of β-carotene, lutein/zeaxanthin, and lycopene was associated with a lower risk of MAFLD after adjusting for various covariates. Compared to the lowest tertile, a significant inverse correlation was observed between the highest total lycopene intake and MAFLD among females in the gender subgroup analysis. Restricted cubic spline regression analysis revealed a U-shaped association between lycopene consumption and MAFLD risk (P < .001), with an inflection point of approximately 9.48 mg/day. Moreover, the nonlinear relationship was particularly significant in females and absent in males. In summary, increased β-carotene, lutein/zeaxanthin, and lycopene consumption was associated with a decreased risk of MAFLD. The relationship between total lycopene intake and MAFLD was nonlinear, primarily in females. These findings have significant implications for the potential prevention and management of MAFLD.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) conducted a cross-sectional in Metabolic dysfunction-associated fatty liver disease (MAFLD) (n=2,722). Carotenoid intake (β-carotene, lutein/zeaxanthin, and lycopene) vs. Lowest tertile of intake was evaluated on Risk of MAFLD (p=<.001). Increased intake of β-carotene, lutein/zeaxanthin, and lycopene was associated with a lower risk of MAFLD, with a U-shaped association for lycopene (P<.001) primarily observed in females.
Synapse has enriched 10 related papers. Consider them for comparative context: